Patents by Inventor Yukiko Tone

Yukiko Tone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antisense nucleic acids
    Patent number: 11981894
    Abstract: The present invention provides an oligomer which allows exon 45 skipping in the human dystrophin gene.
    Type: Grant
    Filed: November 17, 2020
    Date of Patent: May 14, 2024
    Assignees: NIPPON SHINYAKU CO., LTD., NATIONAL CENTER OF NEUROLOGY AND PSYCHIATRY
    Inventors: Yukiko Enya, Yuichiro Tone, Shin'ichi Takeda, Yoshitsugu Aoki
  • MOUSE GLUCOCORTICOID-INDUCED TNF RECEPTOR LIGAND IS COSTIMULATORY FOR T CELLS
    Publication number: 20090181459
    Abstract: The present invention provides mGITRL proteins, nucleotide molecules encoding same, mGITRL messenger RNA molecules, methods of expressing a recombinant gene in an immune cell and of stimulating CD4+CD25? T cells, comprising same or comprising agonist anti-GITR antibodies.
    Type: Application
    Filed: September 19, 2008
    Publication date: July 16, 2009
    Inventors: MASAHIDE TONE, YUKIKO TONE
  • Mouse glucocorticoid-induced TNF receptor ligand is costimulatory for T cells
    Publication number: 20060099171
    Abstract: The present invention provides mGITRL proteins, nucleotide molecules encoding same, mGITRL messenger RNA molecules, methods of expressing a recombinant gene in an immune cell and of stimulating CD4+CD25? T cells, comprising same or comprising agonist anti-GITR antibodies
    Type: Application
    Filed: November 2, 2005
    Publication date: May 11, 2006
    Inventors: Masahide Tone, Yukiko Tone
  • Cytorhodin S derivatives and a process for their preparation
    Patent number: 5028698
    Abstract: Cytorhodin S derivatives, especially cytorhodin S-immunoglobulin complexes are disclosed. Cytorhodin S possesses very high anticancer activity, but the complexes act more selectively on cancer cells and are more useful as an anticancer agent. New intermediate derivatives are also useful as an anticancer agent.
    Type: Grant
    Filed: January 18, 1990
    Date of Patent: July 2, 1991
    Assignee: Hoechst Japan Limited
    Inventors: Yukiko Tone, Toshiro Iwahashi, Etsuko Ohkouchi, Hiroshi Kitagawa, Isamu Sugawara, Hiroshi Okazaki, Akio Fukuda, Hans G. Berscheid, Hitoko Numata, Junko Usui, Shunji Senda, Akihiko Matsuo, Hiroshi Watanabe, Itsuo Kurobane